These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 24371231

  • 1. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.
    de Miguel FJ, Sharma RD, Pajares MJ, Montuenga LM, Rubio A, Pio R.
    Cancer Res; 2014 Feb 15; 74(4):1105-15. PubMed ID: 24371231
    [Abstract] [Full Text] [Related]

  • 2. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
    Chang HL, Lin JC.
    Biochim Biophys Acta Mol Cell Res; 2019 Dec 15; 1866(12):118550. PubMed ID: 31491447
    [Abstract] [Full Text] [Related]

  • 3. Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer.
    Langer W, Sohler F, Leder G, Beckmann G, Seidel H, Gröne J, Hummel M, Sommer A.
    BMC Genomics; 2010 Nov 30; 11():676. PubMed ID: 21118496
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y, Sun N, Lu Z, Sun S, Huang J, Chen Z, He J.
    Cancer Lett; 2017 May 01; 393():40-51. PubMed ID: 28223168
    [Abstract] [Full Text] [Related]

  • 7. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.
    Gout S, Brambilla E, Boudria A, Drissi R, Lantuejoul S, Gazzeri S, Eymin B.
    PLoS One; 2012 May 01; 7(10):e46539. PubMed ID: 23071587
    [Abstract] [Full Text] [Related]

  • 8. SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells.
    Shultz JC, Goehe RW, Murudkar CS, Wijesinghe DS, Mayton EK, Massiello A, Hawkins AJ, Mukerjee P, Pinkerman RL, Park MA, Chalfant CE.
    Mol Cancer Res; 2011 Jul 01; 9(7):889-900. PubMed ID: 21622622
    [Abstract] [Full Text] [Related]

  • 9. Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells.
    Gonçalves V, Henriques AF, Pereira JF, Neves Costa A, Moyer MP, Moita LF, Gama-Carvalho M, Matos P, Jordan P.
    RNA; 2014 Apr 01; 20(4):474-82. PubMed ID: 24550521
    [Abstract] [Full Text] [Related]

  • 10. Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage.
    Comiskey DF, Jacob AG, Singh RK, Tapia-Santos AS, Chandler DS.
    Nucleic Acids Res; 2015 Apr 30; 43(8):4202-18. PubMed ID: 25845590
    [Abstract] [Full Text] [Related]

  • 11. Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer.
    Misquitta-Ali CM, Cheng E, O'Hanlon D, Liu N, McGlade CJ, Tsao MS, Blencowe BJ.
    Mol Cell Biol; 2011 Jan 30; 31(1):138-50. PubMed ID: 21041478
    [Abstract] [Full Text] [Related]

  • 12. Protein arginine methyltransferase 6-dependent gene expression and splicing: association with breast cancer outcomes.
    Dowhan DH, Harrison MJ, Eriksson NA, Bailey P, Pearen MA, Fuller PJ, Funder JW, Simpson ER, Leedman PJ, Tilley WD, Brown MA, Clarke CL, Muscat GE.
    Endocr Relat Cancer; 2012 Aug 30; 19(4):509-26. PubMed ID: 22673335
    [Abstract] [Full Text] [Related]

  • 13. Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC.
    Das S, Anczuków O, Akerman M, Krainer AR.
    Cell Rep; 2012 Feb 23; 1(2):110-7. PubMed ID: 22545246
    [Abstract] [Full Text] [Related]

  • 14. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
    Lee LN, Kuo SH, Lee YC, Chang YL, Chang HC, Jan IS, Yang PC.
    J Formos Med Assoc; 2005 Aug 23; 104(8):541-8. PubMed ID: 16193174
    [Abstract] [Full Text] [Related]

  • 15. Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer.
    Lo A, McSharry M, Berger AH.
    BMC Cancer; 2022 Dec 16; 22(1):1315. PubMed ID: 36522653
    [Abstract] [Full Text] [Related]

  • 16. Regulation of Mcl-1 by SRSF1 and SRSF5 in cancer cells.
    Gautrey HL, Tyson-Capper AJ.
    PLoS One; 2012 Dec 16; 7(12):e51497. PubMed ID: 23284704
    [Abstract] [Full Text] [Related]

  • 17. A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.
    de Miguel FJ, Pajares MJ, Martínez-Terroba E, Ajona D, Morales X, Sharma RD, Pardo FJ, Rouzaut A, Rubio A, Montuenga LM, Pio R.
    Mol Oncol; 2016 Nov 16; 10(9):1437-1449. PubMed ID: 27555542
    [Abstract] [Full Text] [Related]

  • 18. Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells.
    Chang JG, Yang DM, Chang WH, Chow LP, Chan WL, Lin HH, Huang HD, Chang YS, Hung CH, Yang WK.
    PLoS One; 2011 Nov 16; 6(6):e18643. PubMed ID: 21694768
    [Abstract] [Full Text] [Related]

  • 19. PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing.
    Mao S, Li Y, Lu Z, Che Y, Huang J, Lei Y, Wang Y, Liu C, Wang X, Zheng S, Sun N, He J.
    Cancer Med; 2019 May 16; 8(5):2429-2441. PubMed ID: 30932358
    [Abstract] [Full Text] [Related]

  • 20. SRSF1-Regulated Alternative Splicing in Breast Cancer.
    Anczuków O, Akerman M, Cléry A, Wu J, Shen C, Shirole NH, Raimer A, Sun S, Jensen MA, Hua Y, Allain FH, Krainer AR.
    Mol Cell; 2015 Oct 01; 60(1):105-17. PubMed ID: 26431027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.